[Portal hypertension in pediatrics. I: pathophysiology and clinical aspects]

Alejandro Costaguta1, Fernando Alvarez

  • 1Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Rosario, Argentina. acostagu@arnet.com.ar

Insights

Portal hypertension, a serious condition, arises from increased resistance in the portal vein. Early recognition in pediatric patients is crucial for timely management and preventing severe complications like esophageal varices bleeding.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Vascular Physiology

Context:

  • Portal hypertension is a critical clinical syndrome with severe, life-threatening complications.
  • It is defined by elevated pressure in the portal venous system, specifically a gradient to the inferior vena cava exceeding 5 mmHg.
  • A gradient of 10-12 mmHg significantly increases the risk of bleeding from esophageal varices.

Purpose:

  • To differentiate between prehepatic and intrahepatic portal hypertension in pediatric patients.
  • To highlight the distinct etiologies and prognoses associated with each pediatric model.
  • To emphasize the importance of diagnostic tools like Doppler ultrasound and liver function tests.

Summary:

  • Portal hypertension involves increased resistance to blood flow in the portal axis, leading to serious complications.
  • In children, two models exist: prehepatic (no liver disease) and intrahepatic (with liver disease), each with unique causes and outcomes.
  • Doppler ultrasound and liver function tests are key to distinguishing these pediatric forms.

Impact:

  • Accurate recognition of pediatric portal hypertension by pediatricians is essential for prompt patient management.
  • Timely diagnosis can mitigate the risk of severe complications, such as variceal bleeding.
  • Understanding the different pediatric models aids in tailored treatment strategies and improved patient prognosis.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...